Quantified

MAY 5, 2022

Since the pandemic disrupted in-person sales interactions, sales organizations have had to shift their strategies without much supporting technology. McKinsey found that 80-90% of sales are now done remotely. They can leverage advanced, AI-based software when building a remote sales team that’s effective and efficient.

Training 52

Training Sales Management Sales pitches 52

pharmaphorum

SEPTEMBER 21, 2022

The European Commission has followed the lead of the US FDA and approved AstraZeneca’s Tezspire as an add-on maintenance therapy for patients with severe asthma, becoming the first and only biologic that can be used in all patients, and not restricted to those with specific forms of the disease. billion or more.

Sales 108

Sales Patients Biopharma Medicine 108

Pharmaceutical Technology

JANUARY 30, 2023

According to GlobalData’s Drugs database, there were 22 prophylactic vaccines in development for COVID-19 with sales forecasts available in H2 2022. According to GlobalData’s Drugs database, there were 22 prophylactic vaccines in development for COVID-19 with sales forecasts available in H2 2022.

Sales 52

Sales Leads Competition Medicine 52

Penrod

JUNE 6, 2024

Depending on their business model, life sciences companies typically use Salesforce Sales Cloud, Health Cloud, or Service Cloud as their primary CRM. What is Life Sciences Cloud? The main features aim to improve how med dev and pharma companies conduct commercial and clinical operations.

CRM 52

CRM Food and Drug Administration Healthcare Provider Management 52

pharmaphorum

JANUARY 9, 2023

Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Additionally, its top-selling drug, Myalept or Myalepta, had third-quarter sales of $37.9m. in an all-cash transaction at $14.50

Pharma 85

Pharma Biopharma Management Medicine 85

Pharmaceutical Technology

JANUARY 19, 2023

Antigens such as CD123 and CD33, despite being markers of myeloid cells, are shared with their healthy counterparts, and myeloablation following their depletion often leads to detrimental clinical outcomes. If approved, it could reach sales of $158 million in the 8MM (US, France, Germany, Italy, Spain, the UK, Japan, and China) by 2031.

Marketing 52

Marketing FDA Sales Management 52

Clarivate

JANUARY 23, 2024

forecast peak sales per asset versus the cost of developing an asset or an output measure such as the number of global first world launches). In addition, R&D productivity analyses are in some way associated with actual or future launches or a consequence of the launch, such as resulting sales.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

pharmaphorum

SEPTEMBER 22, 2022

The company said this morning that US sales growth is its main priority, and that it will be led in the near-term by “high-value” new drugs Kisqali (ribociclib), iptacopan, Pluvicto (lutetium Lu 177 vipivotide tetraxetan), remibrutinib, and Scemblix (asciminib).

Management 52

Management Sales Patients Marketing 52

pharmaphorum

OCTOBER 26, 2022

The drug was highlighted at Boehringer’s R&D update earlier this year as one of the most promising candidates among 15 new medicines it plans to bring to market by 2025, fuelled by a €25 billion R&D spend. There are more than 200 lung disorders that can lead to pulmonary fibrosis.

Recruitment 93

Recruitment Prospecting Marketing Patients 93

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

pharmaphorum

OCTOBER 6, 2022

Lilly already has approval for the dual GLP-1/GIP agonist under the Mounjaro brand name as a diabetes therapy and is tipped to make rapid inroads in that market, with EvaluatePharma predicting sales could break the $1 billion barrier in 2024, and $3 billion two years later. billion in 2025 sales.

Sales 52

Sales Marketing FDA Leads 52

MedTechVets

OCTOBER 29, 2024

” A Look Ahead: 2025 and Beyond During the panel, Steve Mapa reflected on the program’s current success and exciting future: “We currently have around 100 active mentors—thank you to each one of you. Mentors are the heart and soul of our program, and our goal for 2025 is to grow that number to 150.”

Consulting 59

Consulting Networking Government Medical 59

PM360

SEPTEMBER 21, 2023

Over the next few weeks, manufacturers will submit a range of clinical, marketing, sales, pricing, and patient data, and then meet with CMS to discuss submissions later this fall. CMS negotiation may lead to additional savings for beneficiaries and for the Medicare program.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

LEVO Health

NOVEMBER 30, 2021

In 2020, social commerce sales were estimated at almost 27 billion dollars in the United States. By 2025, social commerce sales are expected to reach 79.6 In an effort to support vulnerable community members, people are more likely to support practices that promote inclusivity and lead purpose-driven campaigns.

Media 52

Media Healthcare Healthcare Marketing 52

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. Additional payments will be tied to specific research, development, and sales milestones.

Medicine 78

Medicine Pharma Engineering Sales 78

pharmaphorum

OCTOBER 19, 2022

billion (plus royalties on net sales). And, pending approval, Zymeworks is eligible to receive tiered royalties between 10% and 20% on Jazz’s net sales. Under ‘Vision 2025’, Jazz aims to deliver at minimum five novel therapies to patients by the end of the decade. million in potential commercial milestone payments.

Sales 40

Sales Pharmaceutical FDA Patients 40

CloserIQ

DECEMBER 14, 2018

We’ve compiled some of our favorite reads to help you advance in your sales career and build top sales teams. If you lead an SDR team–or are considering building one–you’re inevitably going to hire some green salespeople. Once you hire the right people, you’ll train them on your sales process and then put them on the phones.

Sales 60

Sales Sales pipeline Sales process Recruitment 60

pharmaphorum

OCTOBER 13, 2022

However, there is a problem facing the treatment of osteoporosis, and it is the lack of research into new therapies, leading to a limited pipeline of new treatments coming through. It is projected that this could lead to a situation where the economic burden would be “unsustainable for most healthcare systems,” he concluded.

Marketing 88

Marketing Healthcare Healthcare Leads 88

Integrity Solutions

NOVEMBER 19, 2018

According to an Ernst & Young study , millennials will comprise 75% of the global workforce by 2025. As a millennial myself, I take on my sales role with great ambition and achievement drive, ready to contribute, but there are also things that I know what I want from my company. The question is, will they want to work for you?

Training 74

Training Sales Management Recruitment 74

European Pharmaceutical Review

SEPTEMBER 28, 2023

Known as MITC, or the Moderna Innovation and Technology Centre, the facility is located in Harwell, Oxfordshire and is expected to become operational in 2025. In his current role, Nicolas leads resilience operations as part of Moderna’s manufacturing and quality network.

Manufacturing 98

Manufacturing Government Pharmaceutical manufacturing Pharmaceutical 98

Pharmaceutical Technology

JANUARY 20, 2023

billion in Covid-19 vaccine sales. In a January business update , the company predicted it will make a minimum of $5 billion in new vaccine sales. Construction will start in early 2023, and the UK plans to produce the first mRNA vaccine there in 2025. In 2021, Moderna had a net income of $12.2

Manufacturing 98

Manufacturing Government Sales Pharmaceutical 98

Evolve Your Success

NOVEMBER 28, 2023

He is a fellow podcaster with interviews from notable university professors leading researchers and fourth-thinking podcast hosts. It’s nice to be able to speak with guests that have had been long enough in this space that they now are in a position to be part of something new and game-changing or lead something new and game-changing.

Medical 52

Medical Medical sales Sales Patients 52

Med Device Careers

JANUARY 3, 2022

Heart-related diseases are listed as the leading cause of death worldwide and in the U.S. and the global IC device market is projected to reach over $20 billion dollars by 2025. alone coronary heart disease kills over 360,000 people annually. Diabetes and hypertension are the two biggest risk factors for coronary heart disease.

Specialization 52

Specialization Medical Engineering Healthcare 52

PM360

JUNE 29, 2022

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. markets by 2025 and 1,000 by 2027—and more than half of those practices are expected to be in medically underserved communities.

Retail 97

Retail Marketing Healthcare Healthcare 97

PM360

AUGUST 26, 2024

As you have worked across various sized firms, including your role as President of Merck’s Emerging Business unit as well as CEO of smaller firms; what should the class of 2025 consider as they map out their post-graduation career paths? Adaptability leads to survival, as Darwin showed us, over strength or intellect.

Distribution 52

Distribution Biopharma Healthcare Healthcare 52

PM360

JULY 13, 2023

billion by 2025, growing at a compound annual growth rate of 6.7%. The future of healthcare is undoubtedly digital, and those who embrace this reality will certainly lead the way. During the COVID-19 pandemic, we saw healthcare organizations spend and scramble to implement numerous virtual care point solutions. References: 1.

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

Clarify Health

JULY 13, 2020

However, approximately two-thirds of new drugs fall short of first-year sales expectations. By 2025, several new gene and cell therapies will be coming to market. Pharma sales and marketing “The sales process is going to change dramatically,” Calum said. “It 57% said, “sometimes, for a few types of high-cost therapies.”

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. By 2025, pharma’s investment in AI is expected to reach $3 billion. About Omnes Capital.

Medicine 92

Medicine Patients Healthcare Healthcare 92

Celeritas

NOVEMBER 7, 2022

billion by 2025. High-value AI-driven drones and equipment can harvest inputs with greater accuracy, leading to higher productivity and a significant drop in expenditure. Automated cleaning systems improve hygiene to lower the risk of infection and facilitate the ease of access for waste removal machinery. Heightened Profitability.

Networking 52

Networking Pharmaceutical products Management Transportation 52

Pharmaceutical Technology

APRIL 24, 2023

The rise of biologics In the lead-up to the 2020 boom, Swiss drugmaker Roche spent some $11 billion on biotechnology research and development in 2018. Meanwhile, the Indian biologics market is expected to grow to $12 billion by 2025, with a compound annual growth rate (CAGR) of 22%.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Healthcare Success

OCTOBER 30, 2024

Find out in our latest podcast featuring Danielle Wiley, CEO of Sway Group, a leading influencer marketing agency. I lead all the time I have to make decisions really quickly, because I remember the moment I started leading before I had a company. I was very happy in my job. Here, let's okay. You do this. I'll do it fine.

Marketing 107

Marketing Healthcare Healthcare Networking 107

Clarivate

DECEMBER 14, 2023

With analysts estimating that obesity drug sales could top $100 billion annually , concerns over the financial hit is likely why plans covering 30% of lives do not reimburse Wegovy, per Clarivate Fingertip Analytics data. If 2025 starts with another split Congress or total Republican control, subsidies face a much tougher road for renewal.

Marketing 52

Marketing Healthcare Healthcare Insurance 52